Covance, Inc. (NYSE:CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar wooderino (93.07) Submitted: 10/27/2009 12:35:38 PM : Outperform Start Price: $54.69 CVD Score: -38.54

Showed up on a screen for solid 5 year growth with low debt, cash on hand and still at attractive P/E ratios.

Featured Broker Partners


Advertisement